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Abstract
Background: Adverse drug events (ADEs) as well as other preventable adverse events in the hospital setting incur a
yearly monetary cost of approximately $3.5 billion, in the United States alone. Therefore, it is of paramount importance
to reduce the impact and prevalence of ADEs within the healthcare sector, not only since it will result in reducing
human suffering, but also as a means to substantially reduce economical strains on the healthcare system. One
approach to mitigate this problem is to employ predictive models. While existing methods have been focusing on the
exploitation of static features, limited attention has been given to temporal features.
Methods: In this paper, we present a novel classification framework for detecting ADEs in complex Electronic health
records (EHRs) by exploiting the temporality and sparsity of the underlying features. The proposed framework consists
of three phases for transforming sparse and multi-variate time series features into a single-valued feature
representation, which can then be used by any classifier. Moreover, we propose and evaluate three different strategies
for leveraging feature sparsity by incorporating it into the new representation.
Results: A large-scale evaluation on 15 ADE datasets extracted from a real-world EHR system shows that the
proposed framework achieves significantly improved predictive performance compared to state-of-the-art. Moreover,
our framework can reveal features that are clinically consistent with medical findings on ADE detection.
Conclusions: Our study and experimental findings demonstrate that temporal multi-variate features of variable
length and with high sparsity can be effectively utilized to predict ADEs from EHRs. Two key advantages of our
framework are that it is method agnostic, i.e., versatile, and of low computational cost, i.e., fast; hence providing an
important building block for future exploitation within the domain of machine learning from EHRs.
Keywords: Electronic health records, Adverse drug events, Data mining, Sparse multi-variate features, Temporal
abstraction, Machine learning, Shapelets
Background
Although electronic health records (EHRs) have been
extensively exploited for developing robust predictive
models and for solving challenging predictive model-
ing tasks in healthcare [1, 2], EHRs still present critical
problems that need to be solved so as to fully exploit
the complex interactions and information they contain.
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Recent studies estimate that in the United States adverse
drug events (ADEs), and other preventable adverse reac-
tions in the hospital setting, incur, apart from the human
suffering, a yearly monetary cost of approximately $3.5
billion [3]. Therefore, it is of paramount importance to
reduce the impact and prevalence of ADEs within the
healthcare sector, not only since it will result in reduc-
ing human suffering, but also since it can substantially
reduce the economical strains on the healthcare system.
Although benefit–risk analysis of newly developed drugs
is already conducted during clinical trials, post-marketing
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detection and surveillance are necessary to detect unan-
ticipated events. Clinical trials are normally performed
with a limited sample of patients, who are followed for a
limited period of time. As a result, not all serious adverse
events can be detected prior to market deployment, which
results in drugs being withdrawn due to serious adverse
reactions not detected during clinical trials. To overcome
some of these limitations, several attempts have been
made to manually encode rules for detecting ADEs in
EHRs [4–6]. However, in addition to requiring substan-
tial efforts by domain experts to formulate such rules, the
objectives typically change over time which requires the
manually encoded rules to be frequently updated. More
importantly, however, many ADEs are not identified, due
to the limited knowledge about effects of medical treat-
ments, such as drugs being tested only in limited trials and
under controlled conditions.
Hence, an alternative approach towards ADE detection
is to resort to machine learning for exploiting the con-
stantly growing volume of EHR data, andmore specifically
to effectively exploit the inherently complex nature of
these data sources. Indeed, a lack of investigation in utiliz-
ing EHR predictive modeling for ADEs built on structured
medical data (e.g, laboratory test results) has led to inter-
est in the development of machine learning models, such
as random forests, which can aid in altering the clinical
courses of ADE vulnerable patients [7]. The develop-
ment and application of predictive models in a clinical
setting can result in substantial improvements when it
comes to ADE detection while minimizing the inherent
costs.
The adoption of EHRs has increased the interest
towards secondary use of clinical and medical data by
researchers and practitioners [8, 9]. Examples of the obvi-
ous and detrimental benefits of EHR systems include
public health surveillance, pharmacovigilance, health-
care quality assessment and monitoring [10]. More-
over, the employment of EHRs facilitates opportunities
for ADE investigations to move from individual-level
to population-level research, a facet which has broadly
received increased attention within clinical and transla-
tional research [8].
The vast majority of research on learning from EHRs
has been focusing mainly on four key categories [11]: (1)
comorbidity detection and analysis, (2) patient cluster-
ing, (3) predictive modeling, and (4) cohort analysis and
querying. Specific examples of such categories include:
association rule mining, classification or prediction of
patient conditions such as identification of the smok-
ing status of patients [12], patient safety and automated
surveillance of adverse events [13], comorbidity and dis-
ease networks [6], processing of clinical text [14], identifi-
cation of suitable individuals for clinical trials [15], and the
identification of temporal associations between medical
events and first prescriptions of medicines for signaling
the presence of an ADE [16].
Temporal abstractions of EHRs
Additional complexity is also induced on the EHR fea-
ture space from time series variables which can often be
of different lengths, measured at irregular time intervals,
or exhibit high levels of sparsity. Several attempts have
been made to address this problem, and retrofit stan-
dard machine learning methods for building predictive
models from such feature spaces. One family of studies
resort to handling temporal variables by considering sim-
pler mappings, i.e., converting each time series feature
value to a static representation, also known as temporal
abstraction. Examples of such simple mappings include
the length, average, mean, slope, or the weighted sum of all
values of the time series [17–20]. Although the mapping
heuristics allow standard predictive modeling techniques
to be employed directly, they compromise the quality of
the feature space by nullifying the underlying temporal
information of the variables; information which may be
immensely useful for the predictive task at hand [21]. As
shown in earlier studies and data domains where variables
are time series, and characterized by high missing-value
rates, the best performing temporal abstraction has been
to consider counts of the values in each variable.
An alternative approach is to employ off-the-shelf time
series summarization techniques, where the goal is to
reduce the length of the time series by transforming
them into more compact representations without loss
of information and by preserving the notion of tempo-
ral order. Examples of such summarization techniques
are, among others, the piecewise aggregate approximation
(PAA) [22] and its follow-up version called symbolic
aggregate approximation (SAX) [23, 24], the discrete
Fourier transformation (DFT) [25] in the frequency
domain, and the discrete wavelet transformation (DWT)
[26]. Among those representations, SAX, maps the time
series to a symbolic sequence; in particular, this mapping
is achieved by assigning each continuous value to a symbol
from a discrete alphabet that follows from a Gaussian dis-
tribution. More importantly, SAX is oftentimes preferred
against other representations due to its simplicity [24].
Moreover, a basic concept that has been used exten-
sively for feature-based time series classification is that
of time series shapelets, which typically refer to class-
distinctive time series subsequences [27–29]. In a typical
time series classification problem, an object is described
either by only a single (univariate) or a set (multi-variate)
of time series of equal length, that are measured at equal
time intervals. The multi-variate time series case could
be considered as an equivalent formulation to our prob-
lem, as each feature could be seen as a single “channel” of
a multi-variate time series. Nonetheless, our setup differs
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substantially as in our case: (1) each individual time series
is not necessarily sampled at fixed time intervals and
(2) our multi-variate features are highly sparse, i.e., they
contain many missing values.
Approaches focusing on classification of epidemiologi-
cal longitudinal data [30, 31] handle multi-variate feature
variables by employing what is known as population-
based feature extraction. Population-based methods are,
however, limited to very short time series variables of up
to three measurements, and are not suited for long and
sparse multi-variate features. In fact, the closest approach
and direct competitor of our work is the random dynamic
subsquence method proposed by Zhao et al. [32], where
the main idea is to convert the temporal features to SAX
sequences, choose a representative subsequence for each
feature, and compute the distance of all features to the rep-
resentative. This process results in single-valued features.
Unfortunately, the approach by Zhao et al. [32] suffers
from two main weaknesses: (1) the chosen distance func-
tion, i.e., Levenshtein distance, is highly dependent on the
sequence length and (2) it cannot effectively handle and
exploit the high degree of sparsity in the feature space.
ADE knowledge extraction from EHRs
Previous work automatic detection of ADEs from EHRs
has consisted of a variety of approaches such as discov-
ering statistical links between certain ADEs and drug
dosage [33] alongside natural language processing using
unstructured data such as clinical notes [34, 35]. How-
ever, there remains a deficiency for investigating ADEs
with predictive modelling on structured EHR data. Exist-
ing predictive modelling studies have utilised standard
techniques such as regression for large-scale mining of
ADEs [36] and random forest classifiers applied to clin-
ical codes and measurements [37]. However, what most
studies lack is the exploitation of crucial information
regarding the temporal order of clinical events which
may have a profound impact on the classification per-
formance of particular ADEs. One such approach was
proposed with the objective of detecting ADE signals
focusing on laboratory abnormalities after treatment with
specific medication [38]. The formulation of our paper is
rather different, as in our case we are using all clinical
measurement signals concurrently to learn temporal fea-
tures for building an ADE classifier. These features can
be of any type, normal or abnormal, and they are used
by the classifier as long as they constitute good ADE
predictors.
Recent work by Zhao et al. [32] has incorporated tem-
poral information through the use of symbolic sequence
representations of EHR time series data for the purpose of
ADE detection. In this study we seek to improve upon the
work of Zhao et al. by accounting for and exploiting high
levels of feature sparsity inherent to EHR data.
The main focus of our paper is proposing a predic-
tive modeling based framework that utilizes multi-variate
temporal features, allowing traditional machine learning
algorithms to work for complex and time-evolving data
sources. EHRs contain such complex data, but predictive
modeling methods typically rely on data sources to be in
a structured form, i.e., a tabular format, where objects
(in our case patient records) correspond to rows and
attributes (in our case patient variables) correspond to
columns [39]. Nonetheless, EHR data can rarely fit into
such format due to its inherent complexity, induced, for
example, by the prevalence of longitudinal observations. A
clinical variable for a particular patient, for instance, is not
always described by a single value, but by a series of val-
ues over time. Consequently, the induced data table may
contain features for which their data type is a time series
variable, instead of a real or categorical variable.
Contributions
Our work focuses on the use of EHR data for the appli-
cation area of ADE detection, as it constitutes a serious
and ubiquitous public health issue. Unfortunately, most
approaches to ADE detection in EHRs do not take into
account the temporality of clinical events, which is critical
for this task, while they cannot effectively handle spar-
sity in the feature space since in a medical context values
are not missing at random (MNAR) [40–42]. The techni-
cal contributions of this paper are, thus, summarized as
follows:
a) we propose a sparse symbolic representation for
multi-variate feature spaces, with emphasis on
temporal features of arbitrary lengths and high
degree of sparsity, i.e., missing values. The proposed
representation is based on the SAX time series
summarization technique as well as on the concept
of s-shapelets, which correspond to class-distinctive
discrete event subsequences;
b) we propose three strategies for dealing with such
feature spaces: (1) length encoding or plain (which
is an extension of Zhao et al. [32]), most-common
encoding or mc, and left-right optimized encoding or
lr;
c) we provide an extensive experimental evaluation of
the three strategies on 15 real datasets taken from
the healthcare domain involving ADEs. Moreover,
we study the utility of the chosen s-shapelets, as well
as their consistency to medical findings in the
context of ADE detection.
Methods
Overview
Our hypothesis is that sparse and unevenly sampled fea-
ture variables from EHRs can serve as strong predictors
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of an ADE. More concretely, given an EHR dataset rep-
resented in the form of unevenly sampled and sparse
multi-variate features, our goal is to infer a classification
model that is able to correctly predict the presence of an
ADE for a previously unseen medical record.
As depicted in Fig. 1, our proposed framework consists
of the following three phases:
Phase A: each feature in the training set is first trans-
formed into a discrete symbolic sequence represen-
tation.
Phase B: a set of candidate subsequences is generated
from the discretized features, which are then evalu-
ated based on their class-distinctive power (referred
to as utility), and finally the set of subsequences with
the highest utility, called s-shapelets, is generated.
An important component of this phase concerns the
way empty data records, i.e., records with empty
sequences, are processed. Towards this end we pro-
pose three strategies for handling and exploiting
empty sequence features.
Phase C: using the s-shapelets extracted from the train-
ing set, each multi-variate data feature (of the train-
ing and test sets) is converted to a real-valued
feature.
Definitions and problem formulation
We now provide some basic definitions and the formula-
tion of the problem at hand.
Definition 1 A time series S = {s1, . . . , sd} is an ordered
set of d real values, where each sk ∈ R, with |S| = d.
The classification task involves a set of data features,
where each feature is represented by a time series. We
denote such featuresmulti-variate features.
Definition 2 A multi-variate feature space A =
{A1, . . . ,Am} is a set of m multi-variate features, where
each Aj ∈ A is a time series.
Using this multi-variate feature spaceA we can define a
multi-variate object O ∈ A as an instantiation of that fea-
ture space. Moreover, given a set of predefined class labels
Y = {y1, . . . , yσ }, we can define the universe of labeled
multi-variate objects in that space. Due to the particu-
lar prediction task, the experiments only considers binary
labels, σ = 2. However, the proposed strategy handles
multiple labels, i.e., σ > 2 without modification.
Definition 3 Given a multi-variate feature spaceA and
a set of predefined class labels Y , the universe of labeled
multi-variate objects is defined as a set of tuples O =
{(Oi, yi) | Oi ∈ A, yi ∈ Y}, where yi is the class label
assigned to object Oi, ∀(Oi, yi) ∈ O, with i ∈[1, n].
In a typical classification setting, we are given a set of
training objects, where each object is associated with a
class label, called the training set. In our case, we employ
amulti-variate training set, denoted as L, which is simply
drawn from our universe of labeled multi-variate objects
O. In other words, L ⊆ O.
Our task is to learn a classification function f for map-
ping the objects in a multi-variate training set L, defined
as instantiations of the multi-variate feature space A, to
the set of class labels Y . In other words, we want to learn
a mapping f : A → Y , such that for each Oi ∈ L
f (Oi) = yˆi ∈ Y ,∀i ∈ {1, . . . , n} ,
where yˆi denotes the predicted class label for object Oi.
Using the above definitions, the problem studied in this
paper is defined as follows:
Problem 1 Given a universe of labeled multi-variate
data objects O defined over a multi-variate feature space
A, a multi-variate training setL, and a loss function, the
objective of multi-variate feature classification is to learn
a mapping function f : A → Y using L, such that the
Fig. 1 The framework. A graphical representation of the transformation framework
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classification error on (unseen) labeled data objects drawn
from universe O is minimized. The classification error is
expressed by the expectation of the loss function:
E(Oi,yi)∈O[(y, f (Oi))] .
In this work, we will consider the 0/1 loss function:
(y, y′) =
{
0, ify = yˆ
1, otherwise
In the following three subsections we describe each of the
three phases of the proposed framework in detail.
Phase A: Multi-variate feature discretization
The objective of the first phase is to discretize the space
of multi-variate features A, resulting into a new fea-
ture space, where feature values correspond to symbolic
sequences. We denote this target space Aˆ and refer to it
asmulti-variate symbolic feature space. The discretization
process follows four steps: (1) normalization, (2) sum-
marization, (3) symbolic representation, and (4) alphabet
calibration. Since the multi-variate features are practically
instantiated as time series variables, we employ stan-
dard time series normalization, summarization, and sym-
bolic representation techniques for the following steps.
Nonetheless, in principle one could use any alternative
technique for each of the four steps.
Normalization
Each multi-variate feature variable is first z-normalized,
i.e., the observed mean is subtracted by each value while
also dividing by the observed standard deviation. In other
words:
S :=
∑|S|
i=1{si − μ(S)}
σ(S) , (1)
where μ(S) and σ(S) correspond to the mean and stan-
dard deviation of the values of S.
Summarization
Next, the multi-variate features are converted to their
corresponding PAA representations [43]. Given a fixed
parameter w, a time series S of length d can be mapped to
a w-length representation S = {s1, . . . , sw}, where the ith
value of S is computed as follows:
si = wd
d
w i∑
j= dw (j−1)+1
sj . (2)
Hence, PAA results in a length reduction from d to w,
by splitting S into w partitions of equal size, and assigning
each partition the mean value of the points of the original
time series falling into that partition.
Symbolic representation
Next, each value of S¯ is mapped to a discrete symbol
defined over an alphabet  of size α. For this symbolic
representation we employ a standard time series summa-
rization technique called SAX [23, 24].
More concretely, a mapping is defined between R and
an alphabet  of α symbols. One assumption is that each
time series variable is generated by an underlying distri-
bution, e.g., a Gaussian. Next, a set of α − 1 breakpoints
B = {β1, . . . ,βα−1} are defined, so that the area under the
Gaussian normal curve N(0,1) from each pair (βi, βi+1)
is equal to 1/α, assuming that β0 = −∞ and βα = ∞.
Hence, given a desired alphabet size α, the breakpoints
can easily be defined by consulting a statistical table. Once
the breakpoints are obtained, S¯ is mapped to a sequence
of symbols Sˆ as follows: all coefficients that are lower than
the first breakpoint are mapped to the first alphabet sym-
bol, e.g., a; the next set of coefficients with values between
the first and the second breakpoints are mapped to the
second available symbol, e.g., b; and so on. The resulting
symbolic representation Sˆ is called the SAX approxima-
tion of S, defined over a SAX alphabet  of α symbols.
By applying SAX, the initial multi-variate feature space A
is converted to its SAX representation, which defines the
symbolic multi-variate feature space Aˆ =
{
Aˆ1, . . . , Aˆm
}
,
comprising symbolic sequence representations of variable
lengths.
Alphabet calibration
As it can be seen, a parameter to calibrate when using
SAX is the alphabet size α, which corresponds to the num-
ber of symbols that are used for mapping the normalized
time series values. Ideally, a minimum number of sym-
bols is needed to reflect the underlying dynamics of a time
series. Since the latter is typically unknown, the choice of
a proper alphabet size is mostly an empirical task [44].
At the end of Phase A, each multi-variate object O
is converted to its symbolic counterpart, denoted as Oˆ.
Hence, the universe of multi-variate objects O is con-
verted to a universe of labeled symbolic objects, denoted
as Oˆ, and the converted training set is now denoted as
Lˆ, while empty records in a data object are represented
as the empty set (∅). Note that the instantiation in Phase
A replicates the method described by Zhao et al. [32]
to allow for assessing the gain of using the subsequent
phases.
Phase B: sub-sequence enumeration
In the second phase, after the original multi-variate fea-
ture space has been transformed to its symbolic represen-
tation, a pool of candidate representative subsequences is
generated, evaluated, and the subset of most representa-
tive ones is finally selected. The overall objective of this
phase is to identify a class-distinctive subsequence, which
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we denote as s-shapelet, for each multi-variate feature.
This process, which follows three steps, is detailed below.
Subsequence generation
Assume we are given a symbolic sequence Sˆ of length
∣∣∣Sˆ
∣∣∣,
corresponding to an instantiation of feature Aˆi, which is
the symbolic representation of the original multi-variate
feature Ai. A subsequence s of Sˆ is defined as a sampling
of length |s| of contiguous symbols from Sˆ, such that |s| ≤∣∣∣Sˆ
∣∣∣, i.e., s = {Sˆt , . . . , Sˆt+|s|−1
}
, with |s| ≤ t ≤ −
∣∣∣Sˆ
∣∣∣ + 1.
Given the symbolic representation Lˆ of a multi-variate
training set L, and an alphabet size α, we generate a pool
of candidate subsequences, denoted as Sα , by randomly
sampling the sequences in Lˆ. Practically, Sα contains snip-
pets of existing symbolic sequences in Lˆ of arbitrary
lengths in [1,lmax], where lmax is the length of the longest
sequence in Lˆ.
Sub-sequence evaluation
The set of randomly generated subsequences Sα is next
evaluated based on the utility of each sub-sequence. In
our setting, the utility of a subsequence corresponds to
its capability of splitting a training set into two disjoint
partitions that separate the class distribution into pure
subsets. More concretely, given a dissimilarity measure,
D(·, ·), between two discrete event sequences of the same
length, a target sequence Sˆ and another sequence s, with
|s| ≤
∣∣∣Sˆ
∣∣∣, the distance function Dist(·, ·) between s and Sˆ
is defined as follows:
Dist
(
s, Sˆ
)
:= min
s′⊆Sˆ,|s′|=|s|
{
D
(
s, s′
)}
. (3)
Intuitively, the above distance corresponds to the dis-
similarity between s and its best matching subsequence in
Sˆ . Although D(·, ·) can be any distance function for string
matching, in this paper we use the edit distance [45], as
it is one of the most widely used measures for evaluating
string similarity.
We should note that in the approach described in Zhao
et al. [32], referred to as random dynamic subsequence, a
similar idea was used for measuring the distance between
a candidate sub-sequence and a data sequence. The key
difference in our paper is that we employ a modified edit
distance function (Eq. 3), which computes the best sub-
sequence match of candidate s in the target sequence, as
opposed to a full sequence match computed by random
dynamic subsequence. This is a substantial improvement
of the competitor method as in its original version the
used distance function is highly affected by the length
of the target sequence; especially when |s| <<
∣∣∣Sˆ
∣∣∣, the
distance value becomes meaningless. In our case, the
solution we propose (Eq. 3) makes the distance function
invariant to the length difference of the two compared
sequences.
Now, consider a training set Lˆ, as converted by phase A,
and assume that it consists of k class labels. Moreover, let
p(yi) be the proportion of sequences belonging to class yi,
i ∈[ 1, k], the entropy of Lˆ can be defined as:
I
(
Lˆ
)
:= −
k∑
i=1
p(yi)log(p(yi)). (4)
Furthermore, if we partition Lˆ into q disjoint subsets{
Lˆ1, . . . , Lˆq
}
, the total entropy of the partitioning can be
computed as:
I
({
Lˆ1, . . . , Lˆq
})
:=
q∑
i=1
∣∣∣Lˆi
∣∣∣∣∣∣Lˆ
∣∣∣ I
(
Lˆi
)
. (5)
Given the definition of entropy, the we can define the
information gain a particular partitioning strategy yields
on a dataset Lˆ, as:
Gain
({
Lˆ1, . . . , Lˆq
})
:= I
(
Lˆ
)
− I
({
Lˆ1, . . . , Lˆq
})
.
(6)
The utility of a sub-sequence in our pool of candidates
Sα is computed following the approach by Ye et al. [46].
More precisely, for each subsequence s ∈ Sα , we com-
pute the dissimilarity between s and all the sequences
in Lˆ, using function Dist(·, ·) (Eq. 3) to induce a parti-
tioning of Lˆ into two disjoint subsets Lˆ1 and Lˆ2. For
simplicity, we consider two-way splits, i.e., q = 2, but
the approach is generalizable to any number of partitions.
Consequently the information gain given by s is evaluated
(using Eq. 6) and measures the ability of s to separate Lˆ
into two partitions with class distributions of low entropy.
Finally, let Sˆ denote a symbolic sequence of an object’s
feature in Lˆ. To maximize the information gain, we seek
for a distance threshold δ, such that each Sˆ ∈ Lˆ is assigned
to Lˆ1 ifDist(s, Sˆ) < δ or to Lˆ2, otherwise. Next, we extend
the previous equation to define the gain achieved by a sub-
sequence s with a given distance threshold δ as follows:
Gain
(
s, δ, Lˆ
)
:= Gain
({
Lˆ1, Lˆ2
})
, (7)
where Lˆ1 =
{
Sˆ∈ Lˆ : Dist
(
s, Sˆ
)
<δ
}
and Lˆ2 ={
Sˆ∈ Lˆ : Dist
(
s, Sˆ
)
≥δ
}
. In particular, we are looking for
the value of δ inducing a split of Lˆ with the lowest possi-
ble entropy. More concretely, inspired by the definition of
optimal split point given in Ye et al. [46], we define such
distance threshold as:
δosp
(
s, Lˆ
)
:= argmax
δ
Gain
(
s, δ, Lˆ
)
. (8)
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Algorithm 1 sketches the evaluation process described
above, while Fig. 2 depicts a graphical example.
Algorithm 1 Subsequence-Evaluation
1: input subsequence s, training set Lˆ and a set of class labels Y : {Yi}ni=1
2: best_gain, δosp ← 0
3: for δ ∈ (0,maxSˆ∈Lˆ Dist
(
s, Sˆ
)
do
4: Lˆ1 ←
{
Sˆ ∈ Lˆ : Dist
(
s, Sˆ
)
< δ
}
5: Lˆ2 ←
{
Sˆ ∈ Lˆ : Dist
(
s, Sˆ
)
≥ δ
}
6: split_gain ← Gain
({
Lˆ1, Lˆ2
})
using Y as in Eqs. (4)–(6)
7: if split_gain > best_gain then
8: best_gain, δosp ← split_gain, δ
9: end if
10: end for
11: return best_gain, δosp
Assuming that our multi-variate feature space is sparse,
i.e., a large fraction of the feature space in our raw dataset
contains time series of zero length, represented as ∅, miss-
ing data plays a crucial role when the optimal distance
threshold is computed. In “Exploiting sparsity” section, we
will explain how missing entries should be treated in this
phase, and propose alternative methods to achieve this
goal.
Sub-sequence selection
So far, we have transformed raw multi-variate features
into a symbolic sequence dataset and used the latter to
generate a set of candidate representative subsequences.
We have also defined a way of ranking such candidates
according to their utility, i.e., their ability to separate the
dataset into two partitions with class distributions of low
entropy.
Now, we want to identify the representative sub-
sequence with the highest utility per multi-variate feature
variable. We call this sub-sequence a sequence shapelet or
s-shapelet.
Definition 4 Given a training set L and an alphabet 
of size α, a sequence shapelet or s-shapelet s∗ is a discrete
event sequence defined over , which induces the partition
of Lˆ with the highest information gain, i.e.,
s∗ := argmax
s∈Lˆ
Gain
(
s, δosp(s), Lˆ
)
. (9)
Since an exhaustive search in the sub-sequence space
can easily become infeasible [46, 47], the s-shapelet,
within our framework, is selected from the (finite) set Sα .
Hence, for a given Sα defined over an alphabet  of a
chosen size α, an s-shapelet s∗α is defined as
s∗α := argmaxs∈Sα Gain
(
s, δosp(s), Lˆ
)
. (10)
The alphabet size for which the achieved information
gain is maximized, denoted as α∗, is called the alphabet
size of maximum utility, and is defined as follows:
α∗ := argmax
α∈I Gain
(
s∗α , δosp(s∗α), Lˆ
)
(11)
where I ⊆ N, i.e., is the set of candidate alphabet sizes.
Finally, the overall best s-shapelet s∗, which we call an
optimum s-shapelet, corresponding to the shapelet that
yields the maximum gain among all possible candidates of
Fig. 2 Simple subsequence evaluation. A graphical representation of how the subsequence s =’abba’ is evaluated and the corresponding
optimal distance threshold δosp(abba) is selected. On the top of the figure, a training set Lˆ is represented as a collection of negative (red squares)
and positive (blue circles) sequences; within each class, sequences are arranged in alphabetical order. The total label entropy of Lˆ is equal to
I
(
Lˆ
)
= 0.918. On the bottom, the sequences inD are arranged on an horizontal axis based on their distance Dist(abba, ·) from the subsequence.
Among all of the possible candidate thresholds δ ∈[ 1, 4], the two best are reported in the figure, namely δ = 3 and δ = 4, yielding an information
gain of 0.459 and 0.317, respectively: therefore, δosp(abba) := 3 is chosen as the optimal splitting distance for the subsequence ’abba’
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each alphabet size, is defined as follows:
s∗ := s∗α∗ . (12)
In summary, for each feature Aˆj ∈ Aˆ in the training set
Lˆ, the optimum s-shapelet, s∗
(
Aˆj
)
, is selected which in
fact is the s-shapelet with the highest utility for Aˆj across
all possible alphabet sizes in I . The final product of this
phase is the set ofm optimum s-shapelets, one per feature
in Aˆ, which we denote as Z∗ =
{
s∗
(
Aˆ1
)
, . . . , s∗
(
Aˆm
)}
.
The only missing part of this phase is how we deal
with feature sparsity, i.e., feature values corresponding to
empty sequences. In “Exploiting sparsity” section, we will
describe three strategies for dealing with sparse multi-
variate features.
Phase C: data transformation
The overall process including phases A and B can be
summarized by a function τ(L,w,I ,,α,∅), which takes
as input all parameters of phases A and B, and finally
results in a learned function τ ∗(·), where all parameters
are optimized as described in these two phases. Once τ ∗(·)
has been learned, it can be used to transform any data
object of the original multi-variate space to a set of real-
valued features. In other words, function τ ∗(·) is simply a
mapping, such that
τ ∗ : A → Rm . (13)
Hence, any multi-variate object O ∈ A can be con-
verted to a real-valued feature object, denoted as O˜, by
applying function τ ∗(·) to its original representation, i.e.,
O˜ = τ ∗(O).
In practice, this transformation is performed by com-
puting the distance (Eq. 3) between each s∗ ∈ Z∗ and its
corresponding symbolic object feature. This transforma-
tion is performed to both the training set Lˆ, during the
model training phase, as well as to the test set at prediction
time. Intuitively, our data objects are transformed from
a set of multi-variate features (columns), with each fea-
ture being a time-series variable, to a set of single-valued
features, where each feature value corresponds to the dis-
tance between its symbolic representation to the selected
optimum s-shapelet for that feature.
Finally, we should stress that, again, object instances
with empty records require special attention. To this end,
several design choices are needed in order to investigate
whether or not to consider these empty records and how
to represent them. These choices are described next.
Exploiting sparsity
Throughout the transformation framework, mainly in
Phase B, described in the previous sections, several design
choices need to be made for handling and exploiting the
sparsity of the feature space, i.e., data entries that are miss-
ing not at random. In this section, we highlight the steps
where such choices are critical for exploiting these miss-
ing values towards improving prediction performance. To
this end, we propose three strategies, which we call length
encoding (or plain), most-common encoding (or mc),
and left-right optimized encoding (or lr).
Strategy I: Length encoding (plain)
An encoding for missing entries is first needed when
raw time series are mapped into SAX sequences, which.
as mentioned earlier, are marked with ∅. Based on
Algorithm 1, when a candidate subsequence s is eval-
uated, an optimal distance threshold is determined in
order to compute the information gain achieved by the
data split induced by s. At this step, a decision has to
be taken on whether or not and how to consider empty
sequences (i.e., empty feature records) when computing
the optimal threshold. For example, suppose we have a
very sparse multi-variate training set L, which, after its
conversion to Lˆ, is mapped to a feature space of symbolic
sequences with many empty strings (i.e., having a large
fraction of ∅).
A simple strategy is to apply Algorithm 1 directly (see
lines (4)–(6)), so that the distance between s and ∅ will
be simply equal to the length of the candidate subse-
quence, that is, Dist(s,∅) = |s|. As a result, all empty
feature records will be assigned either to Lˆ1 or Lˆ2 based
solely on the length of s. This strategy is referred to as
length-encoding or plain.
In summary, plain treats empty multi-variate fea-
ture records as regular entries, and replaces them with
the distance between their symbolic representation and
the optimum s-shapelet, that is, it replaces them with∣∣∣s∗ (Aˆj
)∣∣∣ for each feature Aˆj. This approach is a modified
and improved version of random dynamic subsequence
used in Zhao et al. [32]. In particular, our method corrects
for bias introduced by random dynamic subsequences, i.e.,
to favor longer subsequences, using our re-defined sub-
sequence distance measure. As a consequence, we use
plain as a baseline for methods that consider the tem-
poral information, similar to how sl acts as a baseline for
methods that does not consider temporal information in
our experimental evaluation.
Strategy II: most-common encoding (mc)
An alternative strategy is to ignore empty feature records
corresponding to empty sequences, and compute the
optimal distance split by using only non-empty feature
records. We call this strategy most common encoding or
mc. In fact, when building the single-valued features at
training and prediction time, mc replaces ∅s with the dis-
tance value Dist(s∗, ·) that occurs most frequently within
the training set. When dealing with very sparse feature
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spaces, this choice can be interpreted as a way of consid-
ering missing entries as “frequent”.
Consider, for example, the feature space corresponding
to clinical measurements of patients taken over different
time periods. If a clinical measurement has been recorded
only for a relatively small number of patients, in the
corresponding dataset empty feature records will be ubiq-
uitous. Thus, associating a missing entry with the most
frequently (or commonly) observed value will mark it as
a recurring event. Of course, this strategy is not guar-
anteed to work for dense feature sets, while replacing
empty sequences with themost common distancemay not
capture the actual meaning of a missing measure.
Strategy III: Left-right optimized encoding (lr)
To overcome the limitations of both simple length-
encoding and most-common value encoding, we intro-
duce a third strategy, which we call left-right encoding or
lr. When evaluating a distance threshold for a given sub-
sequence and building the resulting split
{
Lˆ1, Lˆ2
}
(lines
(4) and (5) of Algorithm 1), lr tries to assign all of the
∅s either to Lˆ1 (left) or to Lˆ2 (right), and selects the
option yielding the highest information gain. According to
this choice, the distance of a candidate s-shapelet to ∅ is
computed as follows:
Dist(s,∅) :=
⎧⎨
⎩
0 ∅ → Lˆ1
max
Sˆ∈Lˆ
Dist
(
s, Sˆ
)
∅ → Lˆ2 (14)
This additional computation is performed when decid-
ing on the splitting distance value and does not affect the
remaining transformation steps. Figure 3 provides a con-
crete example of the way in which lr selects the best
s-shapelet. The above strategy also keeps track of the
assignments that yield the overall maximum gain, that is,
Dist(s∗(Aj),∅), j = 1, . . . ,m, and uses this value to replace
missing entries at both training and prediction time.
In “Utility of s-shapelets selected by lr vs. plain”
section, we elaborate on the lr strategy in terms of inter-
pretability and show that a dynamic encoding of miss-
ing data can (also) help understand the s-shapelet that
has been selected for classifying a multi-variate feature
dataset.
Data source
The experiments carried out in this work are based on
HealthBank [1, 48], which is an EHR database containing
de-identified health records for approximately 1.2 million
patients admitted to a hospital or local care facility in the
Stockholm County region. The data was collected dur-
ing 2009 to 2015 by Karolinska University Hospital. The
data source contains a total of 11,623 unique diagnoses
codes defined by ICD10-SE codes (The 10th revision of
the International Statistical Classification of Diseases and
Related Health Problems).
ADEs are reported using codes from the seven ADE cat-
egories proposed by Stausberg and Hasford [49]. Among
these, A.1 and A.2 – a drug-related and a drug- or other
substance-related causation was noted in the diagnosis
code, respectively – indicate a clear sign of an ADE occur-
rence and are, hence, included as possible datasets in this
study. Note that our data source does not contain a suffi-
cient number of patient covering all of the ADE categories
mentioned by Stausberg and Hasford [49].
Empirical evaluation
We formulate our experiments as binary classification
tasks. Hence, for each ADE we create a dataset where data
examples correspond to patients that either have or have
not been assigned with the corresponding ADE diagnosis
code. In each dataset, positive examples are those patients
who have been diagnosed with a specific ADE, while neg-
ative examples are those patients who have been given a
diagnosis code that belongs to the same disease taxon-
omy, i.e., sharing the same first three levels of the ICD-10
hierarchy, but is not an ADE. For example, if the ADE
under consideration is I95.2 (Drug-induced hypotension),
patients who share the same code up to the third position
are considered as negative examples, i.e., I95.* (Hypoten-
sion) (where * denotes any character) except for I95.2. In
the experiments, we include inpatient encounter, but only
predict the possibility of an ADE for their last encounter.
Datasets
We have selected all ADEs belonging to A.1 or A.2 [49]
in our EHR data source (see Table 1), which have also
been assigned to at least 50 patients by practicing physi-
cians at the respective hospital and clinical department.
Patients are described by the set of clinical laboratory test
measurements, encoded using the NPU system [50] (see
Additional file 1 for information about the least sparse
codes), recorded for up to 90 days before the occurrence
of each particular ADE, but not including the time point
when the target ADE is assigned. In fact, we expect that
using a time window of 90 days, and not include all past
events, is more informative since recent events are likely
to influence the target more than older events. Investi-
gating the effect of the window size parameter and its
optimal value is outside the scope of this study, however,
it is not expected to have any major impact on the relative
performance of the investigated approaches.
The clinical database, collected from Karolinska University
Hospital in Stockholm, Sweden, consists of medical
records for 1.2 million patients from the Stockholm region
during a 7 year period (2009–2015). The database include
1877 unique clinical measurements from laboratory tests.
In the database, each clinical laboratory test corresponds,
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therefore, to a multi-variate feature in each ADE dataset.
We considered a collection of 15 ADE datasets, where
each dataset contained at most 80% of non-empty entries,
i.e., had a sparsity of at least 20%. Table 2 provides an
overview of the number of features in each ADE dataset
and Table 1 gives an overview of the patient charac-
teristics per dataset regarding average age and gender
distribution.
Benchmarkedmethods
The performance of the proposed multi-variate feature
representation framework using the three missing value
strategies, i.e., plain, mc, and lr, has been evaluated
using the Random Forest algorithm (RF, [51]). Since our
proposed framework is model agnostic, we note that
alternative predictive models can be used. The hyper-
parameters for RF have been configured as follows: (i) we
set the number of trees to 100, (ii) information gain was
used as the split criterion (being consistent with the way
random subsequences are evaluated and an s-shapelet is
selected), and (iii) the number of features to consider at
each decision split was set to the default value √m, where
m is the number of features in the dataset.
As a baseline we used a method referred to as sequence
length representation or sl [20]. This representation has
been shown to be the best single-valued representation for
clinical laboratory measurement features in the context of
detecting ADEs in EHRs, compared to several othermulti-
variate feature representation techniques that do not take
into account the temporal order of themeasurements [20].
Alphabet tuning
Following the best practice introduced by Zhao et al. [32],
we include three different configurations for the SAX
alphabet size (α). These are α = {2, 3, 5}, where the small-
est alphabet size is used to reflect two simple states: low
or high, i.e., simply below or above the mean. To allow for
more fine grained representations, both an alphabet size
of three and five are used to indicate that values can be
contained in different regions of the feature value distri-
bution. Since the best choice of α is unknown apriori, we
here employ a simple strategy to let the learning algorithm
dynamically choose the best alphabet size.
Sparsity tolerance
We explored different levels of feature sparsity by intro-
ducing a threshold τsp, which limits themaximum fraction
of missing data that a feature can contain in order to
be selected (and transformed) for training. For instance,
τsp = 0.2 indicates that a feature is accepted for train-
ing, if it contains no more than 20% of empty sequence
records. More specifically, the higher the sparsity thresh-
old the more features are selected to be transformed and,
hence, used by the predictive model, in our case RF.
Fig. 3 Advanced subsequence evaluation. A graphical example of how lr works. The scenario is similar to that of Fig. 2: on the top, a labeled
sequence dataset Lˆ is depicted, which contains both actual and empty sequences; the latter are marked by ∅, while the total entropy of Lˆ is equal
to 0.881. Below the dataset representation, the sequences are arranged on the horizontal line reporting their distance from ’abba’: lr takes into
account two cases, respectively marked with A and B. In A, lr places all ∅s to the left side of the split, by assigning Dist(abba, ∅) := 0; conversely, in
B, empty sequences are placed to the right side, with a distance from the shapelet equal to Dist(abba, ∅) := maxSα∈Lˆ = 4. The optimal distance
threshold is chosen based on the highest split gain among those obtained in A and B. The figure reports, for both cases, two threshold examples,
namely δ = 3 and δ = 4: in particular, δ = 4 turns out to be the best option, due to the gain (0.193) yielded in A. Therefore, δosp(abba) := 4
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Table 1 Positive denotes patients which are ADE positive, whereas Negative corresponds to patients that are ADE negative
Adverse drug event Positive Negative
D61.1: Aplastic anaemia 593 105
Average age 50.3 55.6
Gender distribution (% female) 42.7 49.5
E27.3 Adrenocortical insufficiency 70 259
Average age 61.8 56
Gender distribution (% female) 58.6 58.6
G62.0 Polyneuropathy 96 783
Average age 59.8 72.7
Gender distribution (% female) 47.9 40.1
I95.2 Hypotension 115 1287
Average age 79.3 74.7
Gender distribution (% female) 40.9 49.6
L27.0 Generalized skin eruption 182 468
Average age 60.1 48.7
Gender distribution (% female) 55.5 48.4
L27.1 Localized skin eruption 151 498
Average age 59.8 55.9
Gender distribution (% female) 50.3 54.5
M80.4 Osteoporosis 52 1170
Average age 65.8 70.9
Gender distribution (% female) 71.15 81
O35.5 Damage to fetus by drugs 146 260
Average age 38.5 38.9
Gender distribution (% female) 100 100
T78.2 Anaphylactic shock 131 856
Average age 50.9 45.46
Gender distribution (% female) 50.4 60.7
T78.3 Angioneurotic oedema 283 720
Average age 56.4 42.35
Gender distribution (% female) 59 59.9
T78.4 Allergy 574 415
Average age 41.2 52.5
Gender distribution (% female) 65.2 51.2
T80.1 Vascular complications 66 609
Average age 66.2 63.2
Gender distribution (% female) 48.5 64.7
T80.8 Infusion complications 538 138
Average age 64.3 60.4
Gender distribution (% female) 65.8 52.2
T88.6 Anaphylactic shock 89 1506
Average age 56.9 58.5
Gender distribution (% female) 51.7 57.6
T88.7 Unspecified adverse effect 1047 550
Average age 60.9 53.6
Gender distribution (% female) 60.2 51.3
Pos. denotes patients which are ADE positive, whereas Neg. corresponds to patients that are ADE negative. The table includes: the total number of patients in each group,
the average age and the gender distribution
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Table 2 For each ADE dataset, the number of features included in the learning process with different sparsity requirements
0.2 0.3 0.5 0.7 0.9 0.95 1.0
D61.1 16 21 23 34 72 90 186
E27.3 11 12 14 19 42 88 137
G62.0 4 11 16 19 40 62 151
I95.2 11 13 14 20 30 56 180
L27.0 4 12 18 25 33 54 162
L27.1 6 11 17 24 35 62 169
M80.4 9 11 14 19 42 62 170
O35.5 1 2 4 15 24 38 73
T78.2 8 9 12 17 29 50 168
T78.3 8 9 12 17 27 43 131
T78.4 8 9 13 17 29 51 194
T80.1 11 13 19 25 33 40 131
T80.8 11 14 19 25 33 43 128
T88.6 11 12 15 21 33 59 202
T88.7 11 12 16 21 33 62 217
In particular, each column corresponds to the maximum percentage of empty time series which is tolerated for a dataset. When τsp = 1.0, all the available features are taken
into account, regardless of the percentage of empty sequences; the only requirement for a feature to be selected in the latter case is that it contains at least one non-empty
sequence
Clearly, when τsp = 1.0, all available features are taken into
account, regardless of the percentage of empty sequence
records.
We refer to Table 2 for the number of features selected
for each ADE dataset and sparsity threshold.
Evaluationmetrics
Since the datasets employed in this study are imbalanced,
we used the Area Under the ROC Curve (AUC) [52, 53],
which has been shown to be a more appropriate clas-
sification performance metric compared to accuracy or
classification error, when the data source is imbalanced
([54, 55]). AUC represents a range of trade-offs between
sensitivity and specificity, and since both are invariant to
the actual balance between classes in the test set, AUC is
not biased towards the majority class. Finally, all the AUC
results reported in this paper are obtained by stratified
10-fold cross-validation.
Results
Sparsity tolerance of baseline
We first investigate how an effective single-valued fea-
ture representation, such as sl, can be affected in terms
of predictive performance in the presence of different
levels of sparse multi-variate features. Since sl is using
the length of the multi-variate feature value (i.e., the
length of the sequence assigned in a feature record) as
its single-valued representation, empty sequences will be
a b
Fig. 4 Evaluation of random forest. a The AUC obtained by RF on a selection of ADE datasets with increasing sparsity threshold τsp . Evaluation of
random forest. b The average AUC obtained by RF on all of the 15 datasets with increasing sparsity threshold τsp
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replaced by ∅. Figure 4a depicts the AUC obtained by
RF on a selection of 5 ADE datasets, while Fig. 4b shows
the average AUC on all 15 datasets, while increasing the
value of τsp. We observe that predictive performance in
terms of AUC increases as sparser features are included
in the learning process. Note that although we only
show five datasets in Fig. 4a, the performance is simi-
lar for the remaining datasets, as it can be confirmed in
Table 5.
Sparsity tolerance of plain, mc, and lr
Next, we investigate whether the consideration of the
temporal information provided by the multi-variate fea-
tures can further improve predictive performance for
ADE detection. Moreover, we study whether any further
improvements are achieved when including very sparse
features, and we explore the most efficient way of repre-
senting empty multi-variate feature records. To carry out
these experiments, we train an RF by using the three pro-
posed feature representations, namely plain, mc and lr,
and measure their respective AUCs for each ADE dataset
and for different sparsity levels.
Our findings are depicted in Table 5, where each row
refers to one of the 15 ADE datasets, columns corre-
spond to increasing values of τsp, and each cell reports
the average AUC of the corresponding model, obtained
by stratified 10-fold cross-validation. For each dataset,
the best result is marked in bold. It can be clearly seen
how predictive performance in terms of AUC increases
as sparser columns are included in the learning process.
Indeed, the column corresponding to the best perfor-
mance is that related to the maximum sparsity threshold,
namely τsp = 1.
Overall comparison
Comparing the performance of all four methods (includ-
ing sl) at each sparsity level – the highest AUC reached
for a given threshold is underlined – we can see how
plain and lr are the most effective feature represen-
tations, followed by sl. In particular, lr outperforms
the other strategies (in terms of number of best results
obtained on all of the 15 ADE datasets) for τsp equal
to 0.2, 0.7, 0.95, and 1, while plain is the best method
for τsp = 0.3. For the other two sparsity levels the two
methods perform equally well. When considering the best
overall result on each ADE dataset, lr reaches the highest
AUC on 8 out of 15 cases.
More importantly, one of our main claims is that lr
is the strategy which best takes into account the infor-
mation provided by empty multi-variate feature records.
To further prove this claim, we compare the perfor-
mance of lr against that of plain and sl. Table 3
shows the outcome of comparing lr, plain, and sl
over all datasets and sparsity levels. For each value of
the sparsity threshold, we report the method achieving
the highest AUC on most ADEs, while the number of
ADEs where the method is performing best is indicated
in brackets. The last column of Table 3 refers to the num-
ber of best AUCs obtained by the methods on all of the
ADE datasets regardless of the sparsity threshold. Inspect-
ing Table 3, we can notice that lr is the most accurate
feature representation strategy for almost every sparsity
threshold.
Statistical significance
Furthermore, we provide a statistical analysis of the pre-
vious experiment. Following Demvsar et al. [56] regarding
the case of individual comparisons between methods on
different datasets, we use the Wilcoxon signed-rank test
[57] for rejecting the null-hypothesis that the compared
methods perform equally well. Those entries of Table 3
where the null-hypothesis is rejected within a confidence
interval of 0.05 are marked with an asterisk. In the first
comparison, lr performs statistically better than plain
when τsp = 0.7, 1.0, with a p-value of p < 0.05 in both
cases. Conversely, the two cases in which plain out-
performs lr are not statistically significant. Concerning
the comparison between lr and sl, the null-hypothesis
is rejected for τsp = 0.2, 0.3, 0.5, 0.9 (with p < 0.01),
and τsp = 0.7 (with p < 0.05). Finally, lr proves to
be statistically better (p < 0.05) than sl also when
considering the overall best performance on each ADE
dataset, as it can be noticed from the last column of
Table 3.
Utility of s-shapelets selected by lr vs. plain
Our aim in this section is to explore the differences
with respect to the utility values obtained for the
selected s-shapelets between the strategy that consid-
ers sparsity, i.e., lr, and the strategy that does not, i.e.,
plain. Figure 5, shows the s-shapelet utility, accord-
ing to information gain, of the s-shapelets that have
been generated by using either lr or plain, for all
datasets. In fact, the horizontal axes of the subfigures
show the information gain for the s-shapelets as com-
puted by lr, while the vertical axes report the infor-
mation gain computed by plain. The color intensity
of the point representing each s-shapelet indicates the
sparsity of the multi-variate feature from which it was
selected.
By inspecting Fig. 5, we can clearly see how lr is consis-
tently able to select s-shapelets with a higher information
gain compared to plain. Also, interestingly, we can iden-
tify ADE cases, where the above holds for extremely sparse
features, such as T78.3, T80.8, T88.7, T80.1, L27.1, and
G62.0. As confirmed by our results, this information gain
difference between the two strategies results in a model
with higher classification performance.
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Investigation of three ADEs
We further investigated the top-5 features (i.e., features
with the highest utility) for lr and plain for three
ADEs: E27.3, L27.1, andG62.0. These adverse effects were
chosen since they are relatively frequent and the informa-
tion gain between the baseline and our proposed method
differed the most, i.e., there is a conflicting explanation
between the two models.
These top-5 features are presented in Table 4. For
E27.3 (i.e., adrenocortical insufficiency), which refers to
inefficiency of the hormones cortisol and aldosterone,
the lack of these two hormones can cause the body to
be unable maintain essential life functions. One cause
of this condition is the use of steroids [58], such as
Dehydroepiandro-sterone sulfate, which is the top-1 vari-
able with consistently elevated values in the blood, found
by lr. More importantly, it is well-known in clinical
pharmacology that the lack of aldosterone can cause
persistently low or uncontrolled levels of sodium, potas-
sium, and cortisol in the blood [58]. This has also been
confirmed by the clinical pharmacologists involved in
our study. Interestingly, both sodium and potassium are
included in the list of top-5 features identified by lr.
On the other hand, plain manages to identify rather
obvious features, such as reduced levels of cortisol and
hemoglobin, which are typically present in the occurrence
of adrenal hemorrhage [58].
Regarding L27.1 (i.e., localized skin eruption), both
methods mostly agree on the most informative features,
which include high levels of erythrocytes and increased
bilirubin levels in the liver. Both are reported as signs of
drug-induced skin disorder, with the second one also indi-
cating anemia in the blood, which is a typical cause of
localized skin eruption [59].
Finally, polyneuropathy, which refers to the damage
of peripheral nerves can be medication induced. As
shown in Table 4, calcium is a consistent predictor for
both plain and lr. This also abides to the findings
of Fernybough and Calcutt [60] that reduced or irregu-
lar levels of calcium can indicate peripheral neuropathy.
More importantly, patients with peripheral neuropathy
typically exhibit elevated erythrocyte sedimentation rate
in their blood [61], which is also consistent with our
findings.
In summary, it is clear that both plain and lr man-
age to identify important features that are connected with
the corresponding ADEs. Based on the existing litera-
ture and our consultation with our collaborating clinical
pharmacologists, our findings presented in Table 4 are
not substantially significant as they are already known to
clinical pharmacologists. Nonetheless, they demonstrate
that our proposed method works in practice, while lr
is shown to be highly robust to sparse temporal features
without compromising predictive performance.
Discussion
The classical approach for dealing with time evolving
representations of medical records is to either summa-
rize the data using simple features [17–19] or to employ
population-based feature extraction [30, 31]. However,
these summarization heuristics compromise the quality of
the feature space by either ignoring the temporal dimen-
sion of the data or by simplifying it. The closest related
work is the random dynamic subsequence method [32],
which is included in the experimental evaluation. The
results of our empirical evaluation demonstrate that the
random dynamic subsequence approach suffers from two
main weaknesses: (1) the chosen distance function, i.e.,
Levenshtein distance, is highly dependent on the sequence
length and (2) it cannot effectively handle and exploit the
high degree of sparsity in the feature space. To overcome
these limitations, we first extend the method to allow for
different distance functions and compute these on equi-
length representations, and secondly, we introduce three
novel strategies for inferring the importance of values
missing not at random. As such, our findings in this study
advance the current state-of-the-art in terms of detecting
ADEs from time-evolving and sparsely recorded medical
record systems.
More concretely, we observed how predictive perfor-
mance in terms of AUC increases as sparser features
are included in the learning process when employing the
baselinemethod, sl, which simply employs the number of
recordings (length) per clinical laboratory measurement
as a feature for the ADE prediction task. This suggests that
the presence or absence, as well as the number of times
a clinical laboratory measurement has been taken for a
patient can constitute a promising ADE predictor.
Table 3 Comparison between lr and plain (first row) and between lr and sl (second row), for different values of the sparsity
threshold
0.2 0.3 0.5 0.7 0.9 0.95 1.0 Overall
lr vs plain lr (10) plain (8) plain (8) lr (11)* lr(11) lr(9) lr(10)* lr (9)
lr vs sl lr (13)* lr (14)* lr (13)* lr (10)* lr (13)* lr (10) lr(9) lr (12)*
Each cell of the table reports the method achieving the highest number of best performances (in brackets) among all of the ADE datasets for a particular sparsity level. The
last column refers to the number of best AUCs obtained on the ADE datasets regardless of τsp . An asterisk marks those cases which are proved to be statistically significant
within a confidence interval of 0.05
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Fig. 5 Comparison of plain and lr. The information gain of plain vs lr for all 15 ADE datasets. Overall, we can see that lr captures more
informative s-shapelets, especially as the sparsity of the multi-variate representation increases
Moreover, as far as the three strategies for handling
multi-variate feature sparsity are concerned, our find-
ings suggest that the proposed techniques provide good
trade-offs between feature sparsity and predictive perfor-
mance in terms of AUC. Consequently, this indicates that
strategies that take into account the sparsity of the data
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Table 4 The most important multi-variate features used by the transformation framework for three of the datasets (from left, E27.3,
L27.1 and G62.0)
Adrenocortical insufficiency Localized skin eruption Polyneuropathy
lr plain lr plain lr plain
1 Dehydroepiandro-sterone sulfate Lymphocytes Erythrocytes MCHC Erythrocytes MCHC
2 Potassium ion Cortisol MCHC Erythrocytes MCHC Erythrocytes
3 Neutrophilocytes Hemoglobin Calcium Calcium MCH MCH
4 Lymphocytes Sedimentation reaction Bilirubins Creatininium Bilirubins Calcium
5 Sodium ion Erythrocytes Creatininium Carbamide Calcium Creatininium
typically outperform those that do not. Hence, this study
demonstrates that temporal multi-variate EHR features
of variable length and with high levels of sparsity can be
effectively utilized to predict ADEs.
Furthermore, special attention has to be given on how
to encode empty feature records in the transformed
dataset when evaluating the utility of candidate s-shapelet.
Indeed, the s-shapelet interpretation discussed above can
easily become infeasible when the binary split introduced
by the s-shapelet is affected by a large amount of empty
sequences. For example, consider the feature represen-
tation of sl. According to this strategy, ∅s are replaced
with 0, regardless of the class distribution. The same holds
for plain and mc, which map ∅ with |s| and the most
common observed distance value, respectively. More gen-
erally, a static encoding of missing data, ignoring the
information given by class distribution, affects the qual-
ity of an s-shapelet. Conversely, by employing a strategy
such as lr, the choice of the encoding of empty sequences
dynamically fits the class balance.
One limitation of the current study, is that, while the
framework is step agnostic, a single configuration is eval-
uated in the experiments. As such, there might be con-
figurations that provide further improvements in terms
predictive performance against the state-of-the-art. We
plan to explore this in future studies. Moreover, the novel
framework is only evaluated on a single task (albeit using
many instantiations of different datasets and targets). As
such, it is rather difficult to generalize the results outside
the scope of the current study, i.e., to detect other medical
conditions except for ADEs. However, due to the fact that
the results are consistent between different datasets, the
relative performance of the investigated strategies are not
expected to differ, only the absolute performance.
From a clinical perspective we acknowledge the limita-
tions of the quality of our data sets pertaining to the nature
in which ADEs are underreported by clinicians. ADEs
are often not the primary reason for clinical encounters
and can be seldom investigated or recognized by clin-
icians with a high degree of certainty. For this reason
our negative set may indeed contain a high proportion
of undetected and unreported ADE cases which could
be detrimental to classification performance results. Nev-
ertheless, we emphasize that our classification results
demonstrate a clear ability to differentiate reported ADE
cases from similar non-ADE cases or cases where the
relevant ADE was overlooked during a clinical encounter.
Additionally, for future studies we would wish to exploit,
not only laboratory test data, but medication data due to
the high clinical relevancy of this information for improv-
ing classification and for the potential of uncovering rela-
tions between certain medications and ADEs. For the
purposes of the current study, laboratory test data was uti-
lized as it’s sequential numerical nature was most relevant
for the approach of our framework which involves sum-
marizing numerical medical information for application
with traditional machine learning algorithms. However,
the uncovering of medication-based insights could indeed
validate our approach by discovering known relations
between ADEs and certain medications while also gener-
ating novel hypotheses for medications which contribute
to ADEs under particular conditions.
Conclusions
We have proposed a novel three-phase symbolic trans-
formation framework for classification of complex and
sparse temporal multi-variate feature datasets. These
types of complex features are common in EHRs and
can be effectively used for various prediction tasks, such
as ADE detection. Moreover, applying machine learning
algorithms to learn models from such data is typically
challenging, due to the variable length and the sparsity of
such features. In this study, we proposed and formalized
a way of handling these types of multi-variate and sparse
features, with focus on ADE prediction from EHRs.
Moreover, our experimental analysis demonstrated the
importance of including temporal information in the
multi-variate feature representation, and emphasized
the usefulness of such information when the data features
are extremely sparse. It is worthwhile to note that a pos-
sibly useful empty feature record, although being static,
can add utility to a feature. Moreover, we should mention
that when temporal information is taken into account dur-
ing the transformation process, special attention has to
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Table 5 AUC obtained by RF on 15 ADE datasets: 4 methods are compared, respectively sl, plain, mc and lr
0.2 0.3 0.5 0.7 0.9 0.95 1.0
D61.1 plain 78.151 80.842 80.817 80.909 84.107 84.801 82.484
mc 76.876 78.132 80.163 78.854 81.259 82.946 81.720
lr 77.978 80.720 79.961 79.675 83.624 83.610 81.510
sl 73.846 78.653 78.928 80.756 83.016 82.412 82.817
E27.3 plain 51.916 58.345 56.302 59.870 58.882 62.518 66.854
mc 48.953 50.052 46.695 50.126 61.773 59.444 58.854
lr 58.445 58.637 56.816 61.179 59.170 64.162 67.266
sl 60.763 62.054 59.670 58.718 58.035 4.686 66.500
G62.0 plain 64.443 71.325 75.452 77.247 78.839 79.074 80.279
mc 66.228 72.700 71.376 76.974 74.769 74.146 74.713
lr 64.713 70.756 74.787 77.169 78.992 79.357 79.418
sl 61.473 69.429 76.335 78.379 81.980 81.509 82.222
I95.2 plain 56.157 57.338 54.871 52.257 54.046 59.855 56.369
mc 57.486 57.390 54.750 49.333 53.480 51.742 57.391
lr 58.052 54.797 58.165 53.184 56.145 57.145 56.362
sl 47.671 49.289 51.080 51.509 53.065 54.267 53.943
L27.0 plain 60.374 68.063 66.689 67.815 65.273 67.416 65.322
mc 56.065 62.683 66.766 65.527 67.431 66.443 64.500
lr 56.585 66.422 66.256 67.020 66.277 68.424 66.110
sl 55.400 62.981 61.919 64.648 64.597 65.136 68.271
L27.1 plain 58.130 61.600 63.471 64.835 63.012 62.454 61.798
mc 56.093 55.029 67.179 61.970 64.556 61.222 62.455
lr 58.636 64.100 65.983 66.264 67.196 63.884 64.012
sl 53.709 61.418 62.955 66.461 66.554 67.397 67.316
M80.4 plain 55.646 54.745 59.375 59.029 68.713 67.004 65.396
mc 55.729 55.770 52.641 58.996 66.863 63.000 63.507
lr 55.753 58.056 58.849 59.760 68.912 69.119 67.756
sl 47.933 57.149 52.678 58.414 67.945 65.199 64.845
O35.5 plain 51.650 52.557 64.963 73.161 77.383 78.590 80.298
mc 52.741 52.962 55.361 68.843 70.114 72.079 70.104
lr 52.756 53.551 68.318 76.971 78.332 80.322 81.324
sl 52.401 52.188 67.201 73.696 75.025 78.140 79.142
T78.2 plain 53.028 51.573 56.977 56.538 57.153 58.709 59.229
mc 55.811 54.349 53.146 55.771 53.260 54.417 53.092
lr 52.924 52.369 55.286 59.569 63.066 57.775 59.254
sl 53.113 50.471 50.492 57.561 56.850 58.646 59.421
T78.3 plain 51.177 54.073 52.614 54.575 58.973 59.449 63.647
mc 48.308 50.692 51.378 53.746 56.715 55.334 58.111
lr 51.762 53.238 55.155 56.952 59.213 61.924 66.209
sl 50.514 51.851 54.273 53.531 56.337 59.759 64.728
T78.4 plain 51.937 54.675 58.151 56.976 57.124 56.506 59.162
mc 52.176 55.459 55.644 54.720 53.475 55.145 56.218
lr 54.434 58.122 54.655 57.019 56.627 58.496 58.549
sl 49.903 49.876 47.081 50.235 54.326 56.986 58.444
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Table 5 AUC obtained by RF on 15 ADE datasets: 4 methods are compared, respectively sl, plain, mc and lr (Continued)
0.2 0.3 0.5 0.7 0.9 0.95 1.0
T80.1 plain 78.962 77.270 84.589 83.097 86.832 85.994 84.189
mc 73.207 72.912 73.492 78.945 74.963 79.334 74.592
lr 78.930 80.478 83.233 83.739 84.677 84.879 85.803
sl 75.125 76.542 79.956 81.759 81.413 83.918 82.726
T80.8 plain 80.744 81.769 83.486 83.704 85.648 86.136 86.751
mc 71.968 71.717 76.488 77.570 78.308 78.182 80.725
lr 81.119 81.211 85.431 85.210 86.319 86.715 86.627
sl 80.537 80.973 84.689 85.569 86.332 86.875 87.351
T88.6 plain 61.998 60.731 62.299 62.830 65.113 63.499 62.249
mc 58.342 58.993 63.476 57.263 59.652 59.568 61.812
lr 60.283 60.159 62.019 63.256 60.864 61.744 64.120
sl 57.623 57.248 57.450 57.417 58.190 57.672 60.403
T88.7 plain 58.971 60.742 62.399 62.239 62.552 63.803 65.352
mc 56.875 57.931 62.472 60.892 63.013 62.435 64.209
lr 60.580 60.462 62.803 61.543 62.588 64.137 66.276
sl 60.297 59.862 61.498 61.811 62.259 64.001 65.139
For each ADE, several sparsity threshold are considered, from 0.2 up to 1.0. The AUC reported for each combination is averaged by cross-validation on 10 different dataset
splits. The best result is bold, and the highest AUC for each threshold underlined
be taken when encoding and handling empty sequences.
The results in Table 5 confirm that different treatments
of sparse datasets in a time dependent scenario result in
different impact on the AUC of the resulting model.
Finally, an advantage of the proposed framework is that
its three phases are method agnostic, i.e., the framework
allows for exchanging the sub-tasks of each phase. For
instance, one could use different machine learning mod-
els, different normalization techniques, symbolic approx-
imations, or distance measures. As such, the proposed
framework provides an important building block for
future exploitation with one important avenue for future
work being the evaluation into alternative choices which
may affect the predictive performance of the learned rep-
resentations.
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